duty to release informatiom promptly, page-2

your comments on the timely release of information are completely correct. ASX and ASIC should take a look at this.

notice BTA sold their local rights to RSV drug for an upfront quick fire sale price of 3.5mill. AstraZ took over Medimmune: there's no vote of confidence on their part, the drug was simply inherited in the portfolio. AZ probably wondered why they got desperate calls to buy the local rights, but if someone's desperate to sell, you shrug your shoulders and buy ....at a desperate price.

TT